ClinicalTrials.Veeva

Menu

Biological Investigation of Explanted Endobronchial Lung Valves Study (Bio-EXCEL)

U

University Medical Center Groningen (UMCG)

Status

Enrolling

Conditions

Emphysema or COPD

Treatments

Diagnostic Test: tissue and blood sampling

Study type

Observational

Funder types

Other

Identifiers

NCT04214587
Bio-EXCEL

Details and patient eligibility

About

Rationale:

COPD is a severe, often progressive and currently incurable lung disease which affects both the upper airways (chronic bronchitis) as well as the lower airways (emphysema). In advanced stages of the disease air-trapping severely reduces the ability to breathe and subsequently the quality of life. A highly effective treatment for restoring lung mechanical functionality of these patients is the introduction of bronchoscopic lung volume reduction (BLVR), e.g. implanting small silicone/nitinol valves (EBV) inside the airways to reduce air-trapping. Although successfully investigated in a selected group of severe COPD patients, the effectiveness of the treatment can sometimes be short-lived due to fibrotic and granulation responses and tissue-material interactions.

Objective:

The main objective of this study is to study and understand the underlying biological principles of granulation and fibrotic responses limiting the effectiveness and longevity of BELVR treatment with EBVs, this to investigate the mechanism of action of tissue-device interactions.

Enrollment

150 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Elidgible for EBV treatment

Exclusion criteria

  • Anticoagulation which cannot be stopped prior to the procedure

Trial design

150 participants in 3 patient groups

baseline assessment group
Description:
n=150 patiënts for baseline assessment
Treatment:
Diagnostic Test: tissue and blood sampling
clinical need for reintervention group
Description:
n=20-30 patiënts for re-bronchoscopy
Treatment:
Diagnostic Test: tissue and blood sampling
clinical stable controls
Description:
n=20 stable treated control patiënts
Treatment:
Diagnostic Test: tissue and blood sampling

Trial contacts and locations

1

Loading...

Central trial contact

Jorine Hartman, PhD; Dirk-Jan Slebos, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems